Are you looking for clinical trails? The Eastchester Center for Cancer Care offers many options for patients who are interested in getting involved in clinical trails. If we presently do not have a trial that you would qualify for, we can get you in touch with someone who can help you.
Please call our main number at 718-732-4000 or click here to request more information and someone from our center will contact you.
For specific questions please email Dr. Karen Hoffman at: Karen@eastchestercenter.com

What is a Clinical Trial?

A clinical trial is a protocol designed to see if a new drug or therapy will work on cancer and possibly benefit patients. Doctors and researchers collect information on the benefits, side effects, possible applications of new drugs, as well as new drug combinations and dosage information.
|
What are the phases of Cancer Clinical Trials?
Clinical Trials have four phases:
|
Brand New Drug

PHASE 1 |
Evaluation of DRUG

PHASE II |
Drug Comparison

PHASE III |
Post FDA Evaluation

PHASE IV |
|
Phase I The new drug is tested for safety, side effects and how a drug is administered. A small number of patients are allowed to participate in a Phase I trials. If a Phase I study results show that the drug is safe Phase II begins.
Phase II these protocols involve a larger number of patients and continue to evaluate the safety of the new drug and any less common side effects.
Phase III these protocols compare the new drug to standard therapies to see if the new drug is more beneficial than the current treatment plan.
Phase IV- these protocols continue to evaluate the safety and benefits of drugs that have been approved by the FDA and are available to cancer patients.
What are the benefits and risks of participating in a trial?
The benefits are:
Trial participants have access to new drugs
They can benefit from new therapies, before it is available to the general public.
Participants usually receive closely monitored, high-quality care.
Contribute valuable information that may influence the future of cancer care for others.
The risks are:
The possibility that a new drug treatment is not better than an existing treatment.
Unknown side effects may be worse than side effects of standard treatments
If patients are randomized, they may receive standard care instead of the new treatment. |
| |
| |
|